Optimizing the use of PET with selective internal radiation therapy.

Abstract

Future OncologyVol. 10, No. 15s Symposium PaperOptimizing the use of PET with selective internal radiation therapyPatrick FlamenPatrick Flamen*Nuclear Medicine, Institut Jules Bordet, Université Libre de Bruxelles (ULB), rue Héger Bordet, 1, B-1000 Brussels, Belgium; E-mail Address: patrick.flamen@bordet.beSearch for more papers by this authorPublished Online:5 Dec 2014https://doi.org/10.2217/fon.14.229AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInReddit View articleKeywords: FDG PET-CT responsepatient stratificationselective internal radiation therapytreatment planningReferences1 Flamen P, Vanderlinden B, Delatte P et al. Multimodality imaging can predict the metabolic response of unresectable colorectal liver metastases to radioembolization therapy with yttrium-90 labeled resin microspheres. Phys. Med. Biol. 53(22), 6591–6603 (2008).Crossref, Medline, Google Scholar2 Garin E, Lenoir L, Rolland Y et al. Dosimetry based on 99mTc-macroaggregated albumin SPECT/CT accurately predicts tumor response and survival in hepatocellular carcinoma patients treated with 90Y-loaded glass microspheres: preliminary results. J. Nucl. Med. 53(2), 255–263 (2012).Crossref, Medline, CAS, Google Scholar3 Kumar R, Sharma P, Garg P et al. Role of 68Ga-DOTATOC PET-CT in the diagnosis and staging of pancreatic neuroendocrine tumours. Eur. Radiol. 21(11), 2408–2416 (2011).Crossref, Medline, Google Scholar4 Garin E, Le Jeune F, Devillers A et al. Predictive value of 18F-FDG PET and somatostatin receptor scintigraphy in patients with metastatic endocrine tumors. J. Nucl. Med. 50(6), 858–864 (2009).Crossref, Medline, CAS, Google Scholar5 Seo S, Hatano E, Higashi T et al. Fluorine-18 fluorodeoxyglucose positron emission tomography predicts tumor differentiation, P-glycoprotein expression, and outcome after resection in hepatocellular carcinoma. Clin. Cancer Res. 13(2 Pt 1), 427–433 (2007).Crossref, Medline, CAS, Google Scholar6 Lee JW, Paeng JC, Kang KW et al. Prediction of tumor recurrence by 18F-FDG PET in liver transplantation for hepatocellular carcinoma. J. Nucl. Med. 50(5), 682–687 (2009).Crossref, Medline, Google Scholar7 Kim BK, Kang WJ, Kim JK et al. 18F-fluorodeoxyglucose uptake on positron emission tomography as a prognostic predictor in locally advanced hepatocellular carcinoma. Cancer 117(20), 4779–4787 (2011).Crossref, Medline, Google Scholar8 Lhommel R, Goffette P, Van Den Eynde M et al. Yttrium-90 TOF PET scan demonstrates high-resolution biodistribution after liver SIRT. Eur. J. Nucl. Med. Mol. Imaging 36(10), 1696 (2009).Crossref, Medline, Google ScholarFiguresReferencesRelatedDetails Vol. 10, No. 15s eToC Sign up Follow us on social media for the latest updates Metrics Downloaded 23 times History Published online 5 December 2014 Published in print November 2014 Information© Future Medicine LtdKeywordsFDG PET-CT responsepatient stratificationselective internal radiation therapytreatment planningFinancial & competing interests disclosureP Flamen has received research grants as well as honoraria for lectures from Sirtex Medical Ltd. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.The author would like to thank Rae Hobbs (of Scribe Medical) for her editorial assistance in the development of this paper, funded by Sirtex Medical Ltd.PDF download